BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17368239)

  • 1. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.
    Kolwankar D; Vuppalanchi R; Ethell B; Jones DR; Wrighton SA; Hall SD; Chalasani N
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):388-93. PubMed ID: 17368239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
    Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
    Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.
    Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
    Drug Metab Dispos; 2003 Jun; 31(6):755-61. PubMed ID: 12756208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
    Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing midazolam hydroxylation activity in human liver microsomes.
    He P; Court MH; Greenblatt DJ; von Moltke LL
    Drug Metab Dispos; 2006 Jul; 34(7):1198-207. PubMed ID: 16638818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus.
    Kamdem LK; Streit F; Zanger UM; Brockmöller J; Oellerich M; Armstrong VW; Wojnowski L
    Clin Chem; 2005 Aug; 51(8):1374-81. PubMed ID: 15951320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts.
    Donato MT; Lahoz A; Jiménez N; Pérez G; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
    Drug Metab Dispos; 2006 Sep; 34(9):1556-62. PubMed ID: 16763015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression.
    Sy SK; Ciaccia A; Li W; Roberts EA; Okey A; Kalow W; Tang BK
    Eur J Clin Pharmacol; 2002 Aug; 58(5):357-65. PubMed ID: 12185560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
    Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
    Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum.
    Canaparo R; Finnström N; Serpe L; Nordmark A; Muntoni E; Eandi M; Rane A; Zara GP
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1138-44. PubMed ID: 17880367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.
    Koch I; Weil R; Wolbold R; Brockmöller J; Hustert E; Burk O; Nuessler A; Neuhaus P; Eichelbaum M; Zanger U; Wojnowski L
    Drug Metab Dispos; 2002 Oct; 30(10):1108-14. PubMed ID: 12228187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimodal distribution of renal cytochrome P450 3A activity in humans.
    Haehner BD; Gorski JC; Vandenbranden M; Wrighton SA; Janardan SK; Watkins PB; Hall SD
    Mol Pharmacol; 1996 Jul; 50(1):52-9. PubMed ID: 8700118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.
    Fakhoury M; Litalien C; Medard Y; Cavé H; Ezzahir N; Peuchmaur M; Jacqz-Aigrain E
    Drug Metab Dispos; 2005 Nov; 33(11):1603-7. PubMed ID: 16049125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
    Gibbs MA; Thummel KE; Shen DD; Kunze KL
    Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens.
    von Richter O; Burk O; Fromm MF; Thon KP; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2004 Mar; 75(3):172-83. PubMed ID: 15001968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples.
    Canaparo R; Nordmark A; Finnström N; Lundgren S; Seidegård J; Jeppsson B; Edwards RJ; Boobis AR; Rane A
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):240-8. PubMed ID: 17371528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP3A gene expression in human gut epithelium.
    Kolars JC; Lown KS; Schmiedlin-Ren P; Ghosh M; Fang C; Wrighton SA; Merion RM; Watkins PB
    Pharmacogenetics; 1994 Oct; 4(5):247-59. PubMed ID: 7894497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
    Sugatani J; Wada T; Osabe M; Yamakawa K; Yoshinari K; Miwa M
    Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver.
    Watanabe M; Kumai T; Matsumoto N; Tanaka M; Suzuki S; Satoh T; Kobayashi S
    J Pharmacol Sci; 2004 Apr; 94(4):459-62. PubMed ID: 15107587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.